352820:KRXHYBE Co., Ltd. Analysis
Data as of 2026-03-11 - not real-time
₩353,500.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
HYBE’s share price sits below its 20‑day and 50‑day moving averages while remaining above the long‑term 200‑day average, indicating mixed short‑term momentum despite a bullish overall trend. The RSI hovers in the mid‑40s, suggesting neutral pressure, and the MACD histogram is negative, reinforcing bearish momentum on the short side.
Fundamentally, the company posts robust revenue growth and a respectable gross margin, yet operating and net margins are negative, ROE is marginally below zero, and the forward P/E is nearly double the industry average. The DCF‑derived fair value is far below the current market price, and the dividend yield is minimal, raising concerns about dividend sustainability. Combined with high recent volatility and an “Extreme Greed” market sentiment, the stock appears significantly overvalued at present.
Fundamentally, the company posts robust revenue growth and a respectable gross margin, yet operating and net margins are negative, ROE is marginally below zero, and the forward P/E is nearly double the industry average. The DCF‑derived fair value is far below the current market price, and the dividend yield is minimal, raising concerns about dividend sustainability. Combined with high recent volatility and an “Extreme Greed” market sentiment, the stock appears significantly overvalued at present.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below short‑term moving averages
- Bearish MACD histogram
- Elevated 30‑day volatility
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong revenue growth potential
- Persistent negative operating margins
- Market sentiment at extreme greed
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Brand strength and diversified entertainment assets
- Low beta indicating limited systematic risk
- Uncertain profitability trajectory
Key Metrics & Analysis
Financial Health
Revenue Growth37.80%
Profit Margin-0.03%
P/E Ratio33.9
ROE-0.25%
ROA1.22%
Debt/Equity36.54
Op. Cash Flow₩153.6B
Free Cash Flow₩62.7B
Industry P/E18.2
Technical Analysis
TrendBullish
RSI45.1
Support₩320,500.00
Resistance₩405,500.00
MA 20₩373,725.00
MA 50₩359,370.00
MA 200₩305,660.00
MACDBearish
VolumeDecreasing
Fear & Greed Index78.16
Valuation
Fair Value₩67,841.02
Target Price₩445,640.00
Upside/Downside26.07%
GradeOvervalued
TypeBlend
Dividend Yield0.14%
Risk Assessment
Beta0.31
Volatility50.75%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.